Apotea AB (publ) (STO:APOTEA)
Sweden · Delayed Price · Currency is SEK 76.15
-0.35 (-0.46%)
Sep 2, 2026, 5:29 PM CET
Apotea AB Market Cap
Apotea AB has a market cap or net worth of 7.93 billion as of September 2, 2026. Its market cap has decreased by -25.02% in one year.
Market Cap
7.93B
Enterprise Value
8.12B
Revenue
7.59B
Ranking
n/a
PE Ratio
32.27
Stock Price
76.15
ChartMarket Cap Chart
Since December 6, 2024, Apotea AB's market cap has decreased from 8.63B to 7.93B, a decrease of -8.17%. That is a compound annual growth rate of -4.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 7.93B | -17.43% |
| Dec 30, 2025 | 9.60B | 9.72% |
| Dec 30, 2024 | 8.75B | 1.35% |
| Dec 6, 2024 | 8.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 156.21B |
| Getinge AB | 66.43B |
| Sectra AB | 56.88B |
| Medicover AB | 36.85B |
| BioGaia AB | 11.60B |
| MedCap AB | 8.39B |
| Synsam AB | 8.33B |
| Xvivo Perfusion AB | 8.31B |